BIM
BMY icon

BRC Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

BRC Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-210,189
Closed -$15.5M – 182
2016
Q2 		$15.5M Sell
210,189
-85,979
-29% -$6.08M 2.69% 6
2016
Q1 		$18.9M Buy
+296,168
New +$18.7M 2.81% 12

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BRC Investment Management's BMY Position: Q3 2016 in Review

BRC Investment Management sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 210,189 shares — an estimated $15.5M sold.

BRC Investment Management first reported a position in BMY in Q1 2016 and held it in 2 quarters. The position peaked at $18.9M in Q1 2016. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

  • BRC Investment Management reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
  • BRC Investment Management sold 210,189 Bristol-Myers Squibb shares in Q3 2016, an estimated $15.5M.
  • BRC Investment Management first reported a position in Bristol-Myers Squibb in Q1 2016 and held it in 2 quarters.
  • BRC Investment Management's Bristol-Myers Squibb position peaked at $18.9M in Q1 2016.
  • 1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on BRC Investment Management's 13F filing for Q3 2016, filed 31 Oct 2016.